A personal risk assessment

Genetic Technologies' test products identify the personal genetic risk of developing a specific disease.

Personalised genetic risk profile 

Based on a patient’s risk profile, a healthcare provider will be empowered to recommend more frequent screening, medication or lifestyle changes.

‚Äč

Genetic risk assessment helps individuals and their healthcare provider develop personalised health management plans to promote early detection and treatment of disease.

Roadmap

Q4 2019

Early 2020 pipeline

Mid 2020

Breast Cancer*

Colorectal Cancer*

Type 2 Diabetes

Cardiovascular

Prostate Cancer

Melanoma

*Tests are developed and market launch is scheduled for Q1 2020

BREVAGenplus

Our first to market, clinically validated genetic risk assessment for non-hereditary (sporadic) breast cancer.

GeneType
for Breast Cancer

A personalised breast cancer risk assessment test

GeneType
for Colorectal Cancer

A personalised colorectal cancer risk assessment test

GTG_GTG-Logo.png

© Genetic Technologies Limited 2019